Drug application
MAXITROL (DEXAMETHASONE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE)
Drugs@FDA NDA 050065 · SANDOZ
Key facts
| Drug name | MAXITROL |
|---|---|
| Active ingredients | DEXAMETHASONE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE |
| Application type | NDA |
| Application number | 050065 |
| Company | SANDOZ |
| Dosage forms | OINTMENT, OPHTHALMIC |
| Strength | 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM |
| Marketing status | Prescription |
| TE codes | AT |
| Reference listed drug | Yes |
| Latest submission status date | Jul 19, 1963 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 1–9 Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: